Neurotop Retard 300 mg prolonged - release tablets
Country: Bulgarija
Lingwa: Bulgaru
Sors: Изпълнителна агенция по лекарствата
Fuljett ta 'informazzjoni
(PIL)
28-02-2022
Karatteristiċi tal-prodott
(SPC)
28-02-2022
Ingredjent attiv:
Карбамазепин
Disponibbli minn:
G. L. Pharma GmbH
Kodiċi ATC:
N03AF1
INN (Isem Internazzjonali):
Carbamazepine
Dożaġġ:
300 mg prolonged - release tablets
Sommarju tal-prodott:
Neurotop retard, 300 mg prolonged-release tablets x 50
Data ta 'l-awtorizzazzjoni:
2014-11-27
